期刊文献+

Protective Effects of Oyster Extract Against Hepatic Tissue Injury in Alcoholic Liver Diseases 被引量:1

Protective Effects of Oyster Extract Against Hepatic Tissue Injury in Alcoholic Liver Diseases
暂未订购
导出
摘要 Oyster extract is an effective bioactivity component. It has abundant nutritional value and antiviral, antitumor and im- mune defense fimctions. The role of oyster extract in treating liver injury has been paid more attention. We use Wistar rats to make alcoholic liver disease model through injecting alcohol into rats' stomachs. These rats were randomly divided into five groups: model group, control group, low-dose, middle-dose and high-dose experimental group with a dose of 0.12gkg-1, 0.40gkg-1, and 1.20gkg-1 alcoholic. After nine weeks, serum biomarkers (ALT, AST, TG and TCHO), malondialdehyde (MDA), glutathione (GSH), C3a, CSa, IL-17, TNF-a, anti-MAA-HAS IgC~ CD3+, CD4+, CDS+, NK cell activation and zinc content were assessed. The results showed that the serum biomarkers(ALT, AST, TG and TCHO), MDA content, anti-MAA-HSA IgG, serum C3a, CSa IL-17 and TNF-a levels of oyster extract treatment groups were significantly decreased in comparison with model group. On the contrary, GSH showed ad- verse trend. Serum CD3+, CD4+ and NK cell activation were significantly increased in middle-dose group and high-dose group compared with model group, and there was decrease of CD8+ activity in high-dose group. Plasma Zn level was decreased in model group compared with that in control group. Meanwhile, Mean plasma Zn levels increased dramatically following the dose increase of a given oyster extract. Oyster extract is an effective bioactivity component. It has abundant nutritional value and antiviral, antitumor and immune defense functions. The role of oyster extract in treating liver injury has been paid more attention. We use Wistar rats to make alcoholic liver disease model through injecting alcohol into rats' stomachs. These rats were randomly divided into five groups: model group, control group, low-dose, middle-dose and high-dose experimental group with a dose of 0.12 g kg-1, 0.40 g kg-1, and 1.20 g kg-1 alcoholic. After nine weeks, serum biomarkers(ALT, AST, TG and TCHO), malondialdehyde(MDA), glutathione(GSH), C3a, C5a, IL-17, TNF-ɑ, anti-MAA-HAS IgG, CD3+, CD4+, CD8+, NK cell activation and zinc content were assessed. The results showed that the serum biomarkers(ALT, AST, TG and TCHO), MDA content, anti-MAA-HSA IgG, serum C3a, C5a IL-17 and TNF-ɑ levels of oyster extract treatment groups were significantly decreased in comparison with model group. On the contrary, GSH showed adverse trend. Serum CD3+, CD4+ and NK cell activation were significantly increased in middle-dose group and high-dose group compared with model group, and there was decrease of CD8+ activity in high-dose group. Plasma Zn level was decreased in model group compared with that in control group. Meanwhile, Mean plasma Zn levels increased dramatically following the dose increase of a given oyster extract.
出处 《Journal of Ocean University of China》 SCIE CAS 2014年第2期262-270,共9页 中国海洋大学学报(英文版)
基金 financially supported by Grants from Qingdao Technology Office, Qingdao Technology Developing Plan, 10-3-3-3-11-NSH and 03-3-hh-09
关键词 oyster extract liver diseases ALCOHOL lipid peroxidation 提取物 酒精性 牡蛎 组织损伤 保护作用 肝病 Wistar大鼠 IL-17
  • 相关文献

参考文献50

  • 1Agnieszka, S. C., Jadwiga, D., and Agnieszka, B. J., 2005. Apoptosis of blood mononuclear cells in alcoholic liver cirrhosis: The influence of in vitro ethanol treatment and zinc supplementation. Toxicology, 212:124-134.
  • 2Ajakaiye, M. A., Jacob, A., Wu, R., Zhou, M., Ji, Y., Dong, W., Wang, Z., Qiang, X., Chaung, W. W., Nicastro, J., Coppa, G. F., and Wang, P., 2011. Upregulation of kupffer cell a2A-adrenoceptors and downregulation of MKP-1 mediate hepatic injury in chronic alcohol exposure. Biochemical and Biophysical Research Communications, 409 (3): 406-11.
  • 3Bykov, I., Junnikkala, S., Pekna, M., Lindros, K. O., and Meri, S., 2007. Effect of chronic ethanol consumption on the expression of complement components and acute- phase proteins in liver. Clinical Immunology, 124: 213- 220.
  • 4Bykov, L, Junnikkala, S., Pekna, M., Lindros, K. O., and Meri, S., 2006. Complement C3 contributes to ethanol- induced liver steatosis in mice. Annals of Medicine, 38: 280-286.
  • 5Cohen, J. I., Chen, X., and Nagy, L. E., 2011. Redox signaling and the innate immune system in alcoholic liver disease. Antioxid Redox Signal, 15 (2): 523-34.
  • 6Diehl, A. M., 2002. Liver Disease in Alcohol Abuser, Clinical Perspective. Alcohol, 27: 721.
  • 7Duryee, M. J., Klassen, L. W., and Thiele, G. M., 2007. Immunological response in alcoholic liver disease. World Journal of Gastroenterology, 13 (37): 4938-4946.
  • 8Duryee, M. J., Klassen, L. W., Jones, B. L., Willis, M. S., and Tuma, D. J., 2008. Thiele GM. Increased immuno- genicity to P815.
  • 9cells modified with malondialdehyde and acetaldehyde. International lmmunopharmacology, 8:1112-1118.
  • 10Fernando, H., Kondraganti, S., Bhopale, K. K., Volk, D. E., Neerathilingam, M., Kaphalia, B. S., Luxon,.B. A., Boor, P. J., and Shakeel Ansari, G. A., 2010. 1H and 31p NMRlipidome of ethanol-induced fatty liver. Alcoholism: Clinical and Experimental Research, 34 (11): 1937-1947.

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部